EPICS THERAPEUTICS: what changed
What changed
EPICS THERAPEUTICS
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
filed annual accounts (NBB)
Net result for the year
-€5.8m
2024 · -€4.8m-€954,072
Equity
€9.1m
2024 · €7.9m+€1.2m
Cash
€9.2m
2024 · €8.8m+€415,164
Balance sheet total
€14.7m
2024 · €13.8m+€883,559
Largest movements
Assets
- Current investments +€1.0m
new in 2025: €1.0m
- Receivables within one year -€585,486
down €585,486 (-29.8%), from €2.0m to €1.4m
of which Trade receivables: -€446,735
- Cash +€415,164
up €415,164 (+4.7%), from €8.8m to €9.2m
mainly Contributions, distributions and other (+€7.0m) and Depreciation (+€6.4m)
- Intangible fixed assets +€224,211
up €224,211 (+86.4%), from €259,600 to €483,811
Equity and liabilities
- Contributions +€7.0m
up €7.0m (+54.9%), from €12.7m to €19.7m
of which Contributions outside capital: +€6.9m
- Profit (loss) carried forward -€5.8m
down €5.8m (-120%), from -€4.8m to -€10.6m
- Trade debts +€662,677
up €662,677 (+109%), from €607,201 to €1.3m
- Accrued charges and deferred income -€434,867
down €434,867 (-100.0%), from €435,005 to €138
- Other debts -€360,489
down €360,489 (-100.0%), from €360,538 to €49
Income statement
- Depreciation +€679,607
up €679,607 (+11.9%), from €5.7m to €6.4m
- Financial charges +€335,607
up €335,607 (+162%), from €207,065 to €542,672
- Gross operating margin +€195,801
up €195,801 (+4.8%), from €4.0m to €4.2m
- Staff costs +€101,878
up €101,878 (+3.3%), from €3.1m to €3.2m
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€4.8m
Gross operating margin
+€195,801
Staff costs
-€101,878
Depreciation
-€679,607
Other operating charges
-€4,273
Financial income
-€28,356
Financial charges
-€335,607
Taxes
-€151
Result 2025
-€5.8m
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€1.3m
Investment
-€7.6m
Financing
+€6.8m
Cash 2024
€8.8m
From operations (derived)
+€1.3m
Net result for the year
-€5.8m
Depreciation
+€6.4m
Receivables after one year
+€124,834
Stocks and contracts
+€4,756
Receivables within one year
+€585,486
Deferred charges and accrued income
+€47,827
Trade debts
+€662,677
Tax, wage and social debts
+€46,272
Other debts
-€360,489
Accrued charges and deferred income
-€434,867
Investment (derived)
-€7.6m
Investment in fixed assets (net)
-€6.6m
Current investments
-€1.0m
Financing
+€6.8m
Debts after one year
-€214,039
Current portion of long-term debt
-€21,869
Contributions, distributions and other
+€7.0m
Cash 2025
€9.2m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €13,821,775 | €14,705,334 | +€883,559 | +6.4% |
| Formation expenses | 20 | €5,047 | €6,548 | +€1,501 | +29.7% |
| Fixed assets | 21/28 | €1,465,990 | €1,695,787 | +€229,797 | +15.7% |
| Intangible fixed assets | 21 | €259,600 | €483,811 | +€224,211 | +86.4% |
| Tangible fixed assets | 22/27 | €1,182,555 | €1,187,641 | +€5,086 | +0.4% |
| Land and buildings | 22 | €787,775 | €732,056 | -€55,719 | -7.1% |
| Plant, machinery and equipment | 23 | €333,863 | €281,217 | -€52,646 | -15.8% |
| Furniture and vehicles | 24 | €55,675 | €96,846 | +€41,171 | +73.9% |
| Leasing and similar rights | 25 | - | €74,608 | +€74,608 | |
| Other tangible fixed assets | 26 | €5,243 | €2,914 | -€2,329 | -44.4% |
| Financial fixed assets | 28 | €23,835 | €24,335 | +€500 | +2.1% |
| Current assets | 29/58 | €12,350,738 | €13,002,998 | +€652,261 | +5.3% |
| Amounts receivable after more than one year | 29 | €1,184,365 | €1,059,531 | -€124,834 | -10.5% |
| Other amounts receivable | 291 | €1,184,365 | €1,059,531 | -€124,834 | -10.5% |
| Stocks and contracts in progress | 3 | €39,020 | €34,264 | -€4,756 | -12.2% |
| Stocks | 30/36 | €39,020 | €34,264 | -€4,756 | -12.2% |
| Amounts receivable within one year | 40/41 | €1,965,223 | €1,379,737 | -€585,486 | -29.8% |
| Trade receivables | 40 | €1,107,175 | €660,440 | -€446,735 | -40.3% |
| Other amounts receivable | 41 | €858,048 | €719,297 | -€138,752 | -16.2% |
| Current investments | 50/53 | - | €1,000,000 | +€1.0m | |
| Cash at bank and in hand | 54/58 | €8,780,680 | €9,195,844 | +€415,164 | +4.7% |
| Deferred charges and accrued income | 490/1 | €381,449 | €333,622 | -€47,827 | -12.5% |
| Total equity and liabilities | 10/49 | €13,821,775 | €14,705,334 | +€883,559 | +6.4% |
| Equity | 10/15 | €7,906,432 | €9,112,305 | +€1.2m | +15.3% |
| Contributions | 10/11 | €12,746,479 | €19,746,472 | +€7.0m | +54.9% |
| Capital | 10 | €191,315 | €281,001 | +€89,686 | +46.9% |
| Issued capital | 100 | €191,315 | €281,001 | +€89,686 | +46.9% |
| Contributions outside capital | 11 | €12,555,164 | €19,465,470 | +€6.9m | +55.0% |
| Share premium | 1100/10 | €12,555,164 | €19,465,470 | +€6.9m | +55.0% |
| Profit (loss) carried forward | 14 | -€4,840,047 | -€10,634,166 | -€5.8m | -120% |
| Amounts payable | 17/49 | €5,915,343 | €5,593,028 | -€322,315 | -5.4% |
| Amounts payable after more than one year | 17 | €3,735,816 | €3,521,777 | -€214,039 | -5.7% |
| Financial debts | 170/4 | €3,735,816 | €3,521,777 | -€214,039 | -5.7% |
| Amounts payable within one year | 42/48 | €1,744,522 | €2,071,114 | +€326,591 | +18.7% |
| Current portion of amounts payable after more than one year | 42 | €290,640 | €268,770 | -€21,869 | -7.5% |
| Trade debts | 44 | €607,201 | €1,269,879 | +€662,677 | +109% |
| Suppliers | 440/4 | €607,201 | €1,269,879 | +€662,677 | +109% |
| Taxes, remuneration and social security | 45 | €486,143 | €532,415 | +€46,272 | +9.5% |
| Taxes | 450/3 | €31,970 | €34,303 | +€2,333 | +7.3% |
| Remuneration and social security | 454/9 | €454,173 | €498,112 | +€43,939 | +9.7% |
| Other amounts payable | 47/48 | €360,538 | €49 | -€360,489 | -100.0% |
| Accrued charges and deferred income | 492/3 | €435,005 | €138 | -€434,867 | -100.0% |
| Remuneration, social security and pensions | 62 | €3,103,542 | €3,205,420 | +€101,878 | +3.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,732,446 | €6,412,053 | +€679,607 | +11.9% |
| Other operating charges | 640/8 | €98,904 | €103,177 | +€4,273 | +4.3% |
| Gross operating margin | 9900 | €4,038,507 | €4,234,308 | +€195,801 | +4.8% |
| Operating profit (loss) | 9901 | -€4,896,385 | -€5,486,343 | -€589,958 | -12.0% |
| Financial income | 75/76B | €52,536 | €24,180 | -€28,356 | -54.0% |
| Recurring financial income | 75 | €52,536 | €24,180 | -€28,356 | -54.0% |
| Financial charges | 65/66B | €207,065 | €542,672 | +€335,607 | +162% |
| Recurring financial charges | 65 | €207,065 | €542,672 | +€335,607 | +162% |
| Profit (loss) for the period before taxes | 9903 | -€5,050,914 | -€6,004,835 | -€953,921 | -18.9% |
| Income taxes | 67/77 | -€210,867 | -€210,716 | +€151 | +0.1% |
| Profit (loss) for the period | 9904 | -€4,840,047 | -€5,794,119 | -€954,072 | -19.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€4,840,047 | -€5,794,119 | -€954,072 | -19.7% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.